Clinical Trial Update: Pharmacokinetics of Raltegravir During Third Trimester Pregnancy and Post-Partum

View source ↗

Summary

A clinical trial evaluating the pharmacokinetics of raltegravir during the third trimester of pregnancy and postpartum has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV Infections | Status: WITHDRAWN